Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endocyte, Inc's CEO Discusses Second Quarter Results - Earnings Call Transcript
Seeking Alpha
Friday, August 3, 2012 - 9:16am
tags:
earnings, Endocyte
Gilead inks low-cost HIV drug deal with generics makers
Fierce Pharma
Thursday, August 2, 2012 - 1:16pm
tags:
generics, HIV, Gilead, Mylan, Ranbaxy, Strides Arcolab
Are Pharma Jobs Cut Finally Slowing Down?
Pharmalot
Thursday, August 2, 2012 - 1:14pm
tags:
layoffs
Repligen Earnings: Beats Wall Street Expectations
Wall St. Cheat Sheet
Thursday, August 2, 2012 - 1:13pm
tags:
earnings, Repligen
DUSA's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Thursday, August 2, 2012 - 1:03pm
tags:
DUSA pharmaceuticals, earnings
NeurogesX receives additional notice of allowance covering NGX-1998 in U.S.
Yahoo/Fly on the Wall
Thursday, August 2, 2012 - 1:02pm
tags:
NeurogesX, NGX-1998
Forest Labs Board Wins Glass Lewis Backing In Icahn Proxy Fight
Bloomberg
Thursday, August 2, 2012 - 12:53pm
tags:
Forest Labs, Carl Icahn
Teva Pharm reports strong Q2 revenue
Reuters
Thursday, August 2, 2012 - 12:52pm
tags:
Teva Pharmaceuticals, earnings
Amicus: GlaxoSmithKline And Insiders Are Heavily Buying This Stock
Seeking Alpha
Thursday, August 2, 2012 - 12:32pm
tags:
GSK, Amicus
A Valuation Model For Arena's Belviq
Seeking Alpha
Thursday, August 2, 2012 - 12:31pm
tags:
Arena, Belviq, obesity, Vivus
Halozyme plunges 50% on FDA setback
Marketwatch
Thursday, August 2, 2012 - 12:31pm
tags:
Halozyme, FDA, HyQ, Baxter International
Novo Nordisk And Johnson & Johnson Are Winners In Big Pharma
Seeking Alpha
Thursday, August 2, 2012 - 12:29pm
tags:
JNJ, Novo Nordisk
Bristol-Myers Executive Accused Of Insider Trading
Bloomberg
Thursday, August 2, 2012 - 12:10pm
tags:
insider trading, Bristol-Myers Squibb
Sun Pharmaceuticals Of India Said To Eye Germany’s Stada
Bloomberg
Thursday, August 2, 2012 - 10:25am
tags:
Sun Pharma, Germany, Stada, M&A, India
Osiris Loss Narrower Than Expected
Yahoo/Zacks
Thursday, August 2, 2012 - 10:24am
tags:
earnings, Osiris
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thursday, August 2, 2012 - 10:22am
tags:
cystic fibrosis, Vertex Pharma, AstraZeneca, Gilead, Kalydeco, Pfizer, Rigel Pharmaceuticals, VX-809
Loss at HGSI Wider Than Expected
Yahoo/Zacks
Thursday, August 2, 2012 - 10:20am
tags:
earnings, Human Genome Sciences
Bristol-Myers: hepatitis C drug trial hit by safety issue
Reuters
Thursday, August 2, 2012 - 10:19am
tags:
Bristol-Myers Squibb, hepatitis C, BMS-986094
Dendreon Approaching End Of Road, While Other Immunotherapies Thrive
Seeking Alpha
Wednesday, August 1, 2012 - 11:08am
tags:
Dendreon, Galena Biopharma
Shire calms jitters on ADHD drug growth
Reuters
Wednesday, August 1, 2012 - 11:03am
tags:
ADHD, Shire, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.